Taylor M Ortiz David W Cohen Michael S Kent Pasi A Jänne Daniel B Costa
10.1097/JTO.0b013e3181f8a164
J Thorac Oncol
2011 Jan;6(1):220-2.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/21178719/
Adenocarcinoma / genetics Carcinoma in Situ / genetics Colonic Neoplasms / genetics Lung Neoplasms / genetics Mutation / genetics Proto-Oncogene Proteins / genetics ras Proteins / genetics
Adenocarcinoma / genetics Carcinoma in Situ / genetics Colonic Neoplasms / genetics Lung Neoplasms / genetics Mutation / genetics Proto-Oncogene Proteins / genetics ras Proteins / genetics Case Reports Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Adenocarcinoma / secondary Aged Carcinoma in Situ / pathology Colonic Neoplasms / pathology DNA, Neoplasm / genetics Female Humans Lung Neoplasms / pathology Polymerase Chain Reaction Prognosis Proto-Oncogene Proteins p21(ras) DNA, Neoplasm KRAS protein, human Proto-Oncogene Proteins Proto-Oncogene Proteins p21(ras) ras Proteins
PMC3059558
21178719
KRAS mutation analysis helps to differentiate between pulmonary metastasis from colon adenocarcinoma in situ and primary lung adenocarcinoma
2011